The FDA (Food and Drug Administration) has approved numerous SGLT2 (sodium-glucose cotransporter 2) inhibitors including Invokana and Invokamet for the treatment of type II diabetes. These medications are designed to lower blood sugar levels in adults. Unfortunately, the FDA has warned that these inhibiting drugs can lead to serious medical conditions including DTA (diabetic ketoacidosis), a life-threatening condition caused by excessive acid levels in the bloodstream. As a result, many patients have filed civil lawsuits against the drug manufacturers to recover their financial damages.
Rosenfeld Injury Lawyers LLC represents victims who have been harmed by taking bad medications and other clients who were injured through some form of professional negligence. Our law firm has successfully prosecuted cases Invokana lawsuits for our clients who have suffered injuries just like yours. Our attorneys are available to answer any legal questions on how to receive the monetary compensation you deserve because you were injured through the pharmaceutical giant's negligence. Should you have additional questions, we invite you to contact our office for a free review of your legal rights.
Class Action Lawsuit Update
A panel of federal judges in 2016 grouped more than 100 lawsuits to be heard in federal MDL (multidistrict litigation) court, with the first of the bellwether trials set to be heard in September 2018. Their decision to coordinate these cases will help centralize similar cases to ensure that all plaintiffs receive adequate compensation once the evidence in multiple bellwether cases has been heard and each jury has reached their verdict. These lawsuit trials will be held in the US District Court for New Jersey (MDL #2750).
Many Invokana lawsuits were already filed in state and federal court. However, none of these cases are involved in a class-action lawsuit. Instead, the MDL court provides a “mass-tort” solution that has many of the significant advantages that are similar to class action suits. The attorneys for both the plaintiffs and the defendants can coordinate discovery, settlement negotiation meetings, and trials to offer a quick solution for plaintiffs who need compensation for their damages. While a class action lawsuit provides a group solution to remedy each case, multidistrict litigation cases remain independent.
What is a Class Action Suit?
In a class action lawsuit, a small number of plaintiffs bring an action on behalf of a much larger group of victims. Even though the larger group does not participate in the litigation, the results obtained by the select plaintiff group will be binding on the cases of the non-participating plaintiffs.
Generally, two traits define the larger group: they have common issues in dispute, and they are so numerous that it is unrealistic and impracticable for them all to bring separate actions. So far, there is no class action lawsuit established to handle compensation for injuries allegedly caused by Invokana. There are significant differences between class action lawsuits and individual cases, including presenting personal evidence at trial that affects only the plaintiff and their family members.
Most law firms do not bring class action lawsuits against giant corporations. Instead, the bad drug injury attorneys at Rosenfeld Injury Lawyers LLC focus our attention on your individual Invokana lawsuit. We will present evidence to a judge and jury in your local community courthouse.
Invokana and Ketoacidosis
In the years following the FDA approval of Invokana, many patients began suffering severe side effects by taking the drug including diabetic ketoacidosis. This medical condition is a life-threatening emergency caused by excessive amounts of toxic assets that build up in the bloodstream. Clinical trials have shown Invokana has a significantly higher risk of side effects compared to all other SGLT2 inhibitors.
In 2015, plaintiffs in Pennsylvania and Alabama began filing the first ketoacidosis lawsuits against the Johnson & Johnson subsidiary Janssen Pharmaceuticals after receiving a diagnosis of diabetic ketoacidosis. The lawsuits are based on pharmaceutical negligence citing that the company failed to warn the plaintiffs about life-threatening side effects or perform adequate testing to ensure the medication was safe. Plaintiffs are also accusing Janssen of marketing their drug for unapproved “off-label” use.
Kidney Failure Lawsuits
Other plaintiffs have filed kidney failure lawsuits against Janssen Pharmaceuticals because they began suffering serious side effects after taking Invokana and Invokamet. The attorneys, in this case, stated that the pharmaceutical company should have anticipated the potential risks of serious side effects including kidney failure. However, Janssen only placed a warning of “kidney problems” on the Black Box warning label under “potential side effects.” The attorneys stated that Janssen failed to specifically address on the box label that taking Invokana can increase the potential risk of kidney failure.
FDA Issued Safety Warnings
In May 2015, the FDA released a Safety Communication Warning after receiving twenty reported cases involving ketoacidosis as a result of diabetes medications including Invokana and other SGLT2 inhibitors. Seven months later in December 2015, the federal agency ordered Janssen to update their Invokana warning label after receiving another 73 reports of ketoacidosis from March 2013 through May 2015. The FDA revealed that every patient in their reports received treatment in the emergency room or was hospitalized due to their life-threatening condition.
SGLT2 Inhibitor-Associated Amputation
In May 2017, the FDA ordered Janssen Pharmaceuticals to include additional information on the Invokana Black Box Warning label to alert users of the potential risk of toe, foot, and leg amputations. The federal agency stated that the final results of multiple clinical trials revealed Invokana users have twice the potential risk of amputation compared to patients taking other SGLT2 inhibitor medication.
This added warning was not the first time Janssen was ordered to make alterations to their labeling. Previously, the FDA issued a Safety Communication over concerns of Metformin, an active ingredient in Invokamet. The federal agency stated that every product that contains Metformin must include a statement on the box detailing serious side effects including the increased potential risk of developing lactic acidosis. The FDA release was sent out to health care practitioners and patients who were prescribed the medication.
The detailed information on the Black Box Warning label states that these medications can cause specific conditions including peripheral vascular disease, neuropathy, and foot ulcers. Also, the label states that individuals with a history of amputation may be predisposed to additional amputations after taking the drug. The FDA encourages doctors to closely monitor patients taking Invokana to ensure the medication is discontinued if they develop any complications.
Invokana and Other SGLT2 Inhibitors
Invokana is not the only SGLT2 inhibitor that is known to develop diabetic ketoacidosis or cause kidney failure, heart attack, or the need for an amputation. Many of the same side effects experienced by Invokana users are related to other medications including:
- Xigduo XR
Attorneys representing plaintiffs have made claims that these pharmaceutical manufacturers knew, or should have known, of the potentially serious side effects and life-threatening injuries their medications cause. Instead, these drug makers chose to aggressively promote and market their medication to gain profits while they withheld information of the drug's problems. Their failure to warn patients and doctors of the serious problems associated with the medication might make them legally liable to pay financial compensation to the injured victims.
Other Safety Concerns
Invokana clinical research studies have identified cardiovascular problems that show how the medication can cause urinary tract infections and increase low blood pressure symptoms. Some safety groups, including the ISMP (Institute for Safe Medication Practices), identified many safety concerns when the FDA approved the drug for the treatment of diabetes. The ISMP stated that the medication had yet to be sufficiently tested through a series of clinical trials and had concerns that the risks outweighed the benefits which were the foundation of the drug's FDA approval.
Some safety groups take issue with the medication because there have been significant links to Invokana use and the development of some health conditions including:
- Bone fractures
- Yeast infections
- Bladder and breast cancers
Settling an Invokana Injury Lawsuit
Many attorneys working on behalf of the plaintiffs are coordinating their discovery while their cases are pending across the United States. Soon, the government will begin conducting bellwether cases, so juries can decide it the pharmaceutical companies are at fault and the level of their responsibility to injured plaintiffs. Each jury will be presented with evidence and weigh specific factors to decide how much of a damage award each plaintiff will receive. Some of these factors include:
- The duration and extent of the plaintiff's injuries after taking Invokana
- The cost of medical care associated with treating the patient's injuries
- The number of salaries and wages lost that was caused by time away from work
- The damages to the plaintiff's physical and mental health after suffering injuries from taking Invokana
- The recovery of non-economic damages involving pain, suffering, emotional distress, and mental anguish in the past, currently, and in the future.
- The diminished enjoyment of life and future declining health that the plaintiff will experience due to their long-term injury
Some of these cases are built on the pharmaceutical giant's negligence when they failed to inform the FDA of specific problems associated with the medication. These attorneys state that the drug maker misrepresented the benefits versus risks of taking Invokana.
Their lawsuits also claim the company failed to conduct sufficient safety studies to ensure that the diabetic medication drug was safe, and failed to warn doctors and patients of the serious known side effects caused by taking the SGLT2 inhibiting medication. To successfully resolve a case, the attorney must show how Janssen pharmaceuticals failed to protect the public from the potentially harmful side effects that result from using their medication.
How Much is my Case Worth?
The circumstances and evidence involved in your case are unique. Because of that, determining the value of your lawsuit will require an in-depth consultation and a review of your medical records.
Currently, the claims filed by plaintiffs against Janssen Pharmaceuticals are based on obtaining compensation for medical bills, lost wages, future health care costs, and pain-and-suffering. These personal injury cases are seeking $50,000 or more in compensation. up to $1 million and over in lawsuits involving a wrongful death.
Hire an Attorney to Handle Your Case
The bad drug injury attorneys at Rosenfeld Injury Lawyers LLC understand that the pain-and-suffering you have endured was not your fault but the responsibility of the pharmaceutical giant that markets defective drugs. We have successfully obtained millions on behalf of the victims and their family members to ensure they were adequately compensated to cover their medical expenses, household bills, lost wages, loss of future earnings, pain, suffering, and emotional damage and we can help your family too.
Our legal team encourages you to contact our attorneys today to schedule a free, no-obligation case consultation to discuss the merits of your monetary recovery claim. We accept all personal injury cases, wrongful death lawsuits, and dangerous medication injury claims through contingency fee arrangements. This legal contract postpones the payment of legal services until after we have successfully completed your case through a negotiated settlement or a jury verdict.
Our law firm can resolve your case quickly because we understand your immediate financial burdens. We are proud to offer every client a “No Win/No-Fee” Guarantee, meaning if we are unable to secure financial compensation on your behalf you owe us nothing. All information you share with our law office will stay confidential.
For additional information see the following pages:
- What is Invokana?
- What are the risks of taking Invokana?
- Has the FDA taken any action against the makers of Invokana?
- What does an Invokana lawsuit look like?
- What are the laws surrounding Invokana?
- Have there been any cases or settlements involving Invokana?
- What damages could I recover in my Invokana lawsuit?
- Is there a time limit by when I have to file my Invokana lawsuit?
- Why hire Rosenfeld Injury Lawyers LLC?